About

bottles

Nectar over allergies

We are Nectar and we are on a mission to put an end to allergies.

Nectar test kit, dx

The time is now

120 million Americans suffer from allergies and their associated diseases. It is the #1 chronic condition impacting Americans today and a leading cause of lost productivity for employers around the country.

Nectar’s comprehensive care is here to change that.


AMERICANS SUFFERING FROM ALLERGIES

120 million

Ken Chahine, Founding CEO

A passion for healthcare, for over a decade

Meet Ken Chahine, Founding CEO

Ken is a serial consumer healthcare entrepreneur with a passion for unlocking opportunities in underserved markets facing massive and inefficient consumer pain points. His superpower is his ability to combine his science, law and consumer experiences to develop strategies that deliver an exceptional service to the masses without compromising on the science.

Before founding Nectar, Ken was the EVP and founding executive of AncestryDNA and Ancestry Health, a consumer genealogy and disease risk predisposition testing company. While at AncestryDNA he took DNA testing mainstream and grew the total addressable market from a niche $10M to well over $2B by reinventing the end-to-end consumer experience. During his tenure, he grew the DNA business to over $500M in direct sales, while driving 20% cross sell into the Ancestry subscription business, led the team through hyper-growth, and scaled global operations to over 10M genomic tests annually.

Ken has demonstrated a talent for identifying winning products. Earlier in his career, Ken was the CEO of Helio Health, a company focused on early cancer detection from a simple blood spot, currently in late-stage FDA trials. He was also the CEO of Avigen, a gene therapy company focused on developing cures for monogenic disease. Avigen’s cure for hemophilia and treatment for Parkinson’s Disease were both recently approved in the EU and are on track for approval in the U.S.

Our team of industry professionals

We are a group of seasoned executives that have come together with a common purpose - putting an end to allergies. We champion science for good. And we’re here to change the world for good.

Vivian Arestia

Vivian Arestia

Head of Marketing

Greg Burgess

Greg Burgess

Head of Engineering

Tsega Dinka

Tsega Dinka

Head of Product

Shyam Joshi, M.D.

Shyam Joshi, M.D.

Head of Medical

Ben Oyler

Ben Oyler

Co-founder & Head of Business Ops

Hersh Patel

Hersh Patel

Co-Founder & Head of New Business

Our team of scientific and clinical experts

Our medical board of scientists and clinicians advises and oversees every aspect of our products, to ensure the highest efficacy standards and best treatment that science has to offer.

Kari Nadeau, M.D., PhD

Kari Nadeau, M.D., PhD

Stanford University

Mohamed Shamji, PhD

Imperial College London

John Zwetchkenbaum, M.D.

John Zwetchkenbaum, M.D.

Chief Allergist and Founder of AAPRI